ctDNA

Hands-off isolation technology delivers higher yield and quality of extracellular vesicles, enabling reproducible workflows for clinical research and diagnostics

Could this new test change how early-stage colorectal cancer is treated and improve patient outcomes?

The first phase of the Stratified Medicine Paediatrics program shows that ctDNA blood tests can provide crucial insights for targeting treatments and tracking childhood cancer progression

Join Today's Clinical Lab and Nicole Coufal, MD, PhD, to discuss the single blood test diagnosing multiple infections in pediatric patients

Metabolomics can measure the actual physiological state of an individual, providing new health insights

ctDNA assays can facilitate tracking of a tumor's response to treatment over time

The independent assessment examined five commercially-available assays for tumor DNA sequencing

The test monitors blood levels of DNA fragments released by dying tumor cells as an early indicator of treatment success

Evidence of disease activity from circulating tumor DNA predicts radiographic melanoma progression